Literature DB >> 29683413

Increased Circulating Follicular Regulatory T-Like Cells May Play a Critical Role in Chronic Hepatitis B Virus Infection and Disease Progression.

Xiaojuan Wu1, Zhenzhen Su1, Bei Cai1, Lin Yan1, Yamei Li1, Weihua Feng1, Lanlan Wang1.   

Abstract

Follicular helper T cells (TFH) and follicular regulatory T cells (TFR), subsets of T cells, co-regulate the reactions of germinal center (GC) B cells. TFH provide help to the GC response, while the TFR suppress those processes. Nevertheless, the role of circulating TFR (cTFR) and circulating TFH (cTFH) in chronic hepatitis B virus (HBV) infection remains limited. Twenty healthy controls (HCs), 24 patients with chronic hepatitis B (CHB), 23 with HBV-related liver cirrhosis (LC), and 18 with HBV-related hepatocellular carcinoma were enrolled in our study between October 2015 and September 2016. We detected the frequencies of cTFR-like cells and cTFH-like cells, the percentage of programmed cell death-1 (PD-1), inducible co-stimulator (ICOS), and interleukin-21 (IL-21) expressed on circulating CD4+CXCR5+ T cells by flow cytometry. Compared to the HC group, the percentage of cTFR-like cells and ratio of cTFR-like/cTFH-like were significantly increased in patients with HBV infection. A raised percentage of PD-1 on circulating CD4+CXCR5+ cells and decreased IL-21-producing circulating CD4+CXCR5+ cells were observed in CHB and LC. The production of IL-21 by circulating CD4+CXCR5+ cells was significantly higher in HBeAg negative group than the positive one. Patients with high levels of alanine aminotransferase and HBV-DNA accompanied increased CXCR5+PD-1+CD4+ T cells. In addition, the frequency of cTFR-like cells and the ratio of cTFR-like/cTFH-like were positively correlated with FIB-4 and APRI. Increased cTFR-like cells and impairment of circulating CD4+CXCR5+ T cells might participate in HBV chronic infection and HBV-related diseases.

Entities:  

Keywords:  IL-21; PD-1; chronic HBV infection; circulating follicular helper T cells/cTFH; circulating follicular regulatory T cells/cTFR; liver cirrhosis

Mesh:

Substances:

Year:  2018        PMID: 29683413     DOI: 10.1089/vim.2017.0171

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  9 in total

Review 1.  Control of the Germinal Center by Follicular Regulatory T Cells During Infection.

Authors:  Brodie Miles; Elizabeth Connick
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

2.  Anti-PD-1 Antibody Administration following Hip Fracture Surgery Reverses Immune Dysfunction and Decreases Susceptibility to Infection.

Authors:  Hao Zhang; Chuying Chen; Jiusheng He; Jianzheng Zhang; Zhi Liu; Tiansheng Sun
Journal:  Mediators Inflamm       Date:  2019-04-03       Impact factor: 4.711

3.  HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection.

Authors:  Sara Ferrando-Martinez; Kelly Huang; Angie Snell Bennett; Patricia Sterba; Li Yu; JoAnn A Suzich; Harry L A Janssen; Scott H Robbins
Journal:  JHEP Rep       Date:  2019-06-28

Review 4.  Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation.

Authors:  Caroline Dudreuilh; Sumoyee Basu; Cristiano Scottà; Anthony Dorling; Giovanna Lombardi
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

5.  Serum IL-21 levels predict HBeAg decline during rescue therapy in patients with partial response to nucleos(t)ide analogues.

Authors:  Yue Li; Calvin Q Pan; Shibo Ji; Gaiqin Yan; Jun Cheng; Shunai Liu; Huichun Xing
Journal:  Exp Ther Med       Date:  2021-01-15       Impact factor: 2.447

Review 6.  The Multiple Functions of B Cells in Chronic HBV Infection.

Authors:  Ying Cai; Wenwei Yin
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

7.  Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection.

Authors:  Jiang Qian; Qinhua Yu; Guoqing Chen; Mingxia Wang; Zhao Zhao; Yueyue Zhang; Liannv Qiu
Journal:  Clin Exp Med       Date:  2020-03-23       Impact factor: 3.984

Review 8.  T Cells in Fibrosis and Fibrotic Diseases.

Authors:  Mengjuan Zhang; Song Zhang
Journal:  Front Immunol       Date:  2020-06-26       Impact factor: 7.561

Review 9.  Follicular regulatory T cells: a novel target for immunotherapy?

Authors:  Yao Huang; Zhe Chen; Hui Wang; Xin Ba; Pan Shen; Weiji Lin; Yu Wang; Kai Qin; Ying Huang; Shenghao Tu
Journal:  Clin Transl Immunology       Date:  2020-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.